NRXBF
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC (NRXBF)
$48
About NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC (NRXBF)
NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Bnei-Brak, Israel.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.61
52 Week Low
$0.34
Market cap
28.5M
Dividend yield
0.00%
Volume
50
Avg. volume
816
P/E ratio
-5.91
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.61
52 Week Low
$0.34
Market cap
28.5M
Dividend yield
0.00%
Volume
50
Avg. volume
816
P/E ratio
-5.91